Minerva Surgical, Inc. Stock price

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 11:03:29 2024-02-26 am EST 5-day change 1st Jan Change
0.598 USD +6.79% Intraday chart for Minerva Surgical, Inc. -3.70% -48.89%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2021 52.1M Sales 2022 50.29M Capitalization 6.58M
Net income 2021 -21M Net income 2022 -34M EV / Sales 2021 2.82 x
Net cash position 2021 1.33M Net Debt 2022 32.75M EV / Sales 2022 0.78 x
P/E ratio 2021
-1.68 x
P/E ratio 2022
-0.19 x
Employees 174
Yield 2021 *
-
Yield 2022
-
Free-Float 30.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day-9.82%
1 week-16.42%
Current month-14.83%
1 month-41.67%
3 months-67.63%
6 months-86.54%
Current year-52.14%
More quotes
1 week
0.50
Extreme 0.5
0.64
1 month
0.50
Extreme 0.5
0.85
Current year
0.50
Extreme 0.5
1.53
1 year
0.50
Extreme 0.5
14.00
3 years
0.50
Extreme 0.5
207.40
5 years
0.50
Extreme 0.5
207.40
10 years
0.50
Extreme 0.5
207.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-01-01
Director of Finance/CFO 66 20-06-30
Chief Tech/Sci/R&D Officer 58 10-12-31
Members of the board TitleAgeSince
Chairman 56 23-02-08
Director/Board Member 51 22-07-19
Director/Board Member 59 21-05-31
More insiders
Date Price Change Volume
24-02-26 0.598 +6.79% 1 049
24-02-23 0.56 -9.82% 11,522
24-02-22 0.621 -1.43% 1,013
24-02-21 0.63 +1.45% 301
24-02-20 0.621 -7.31% 3,017

Delayed Quote OTC Markets, February 23, 2024 at 03:12 pm EST

More quotes
Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
More about the company
  1. Stock
  2. Equities
  3. Stock Minerva Surgical, Inc. - OTC Markets
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW